DiaSorin S.p.A. shares are trading close to a resistance zone which currently limits any upside potential. We expect that this level will be broken due to the stock's technical chart pattern. Investors have an opportunity to buy the stock and target the € 204.38.
The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
Thanks to a sound financial situation, the firm has significant leeway for investment.
Over the last seven days, analysts have been revising upwards their EPS estimates for the company.
The stock is in a well-established, long-term rising trend above the technical support level at 123.8 EUR
The company's "enterprise value to sales" ratio is among the highest in the world.
The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 46.75 times its estimated earnings per share for the ongoing year.
The company is not the most generous with respect to shareholders' compensation.
The appreciation potential seems limited due to the average target prices set by the analysts covering the stock.
The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.